Multicenter Analysis of Postoperative Complications in Octogenarians After Radical Cystectomy and Ureterocutaneostomy: The Role of the Frailty Index.


Journal

Clinical genitourinary cancer
ISSN: 1938-0682
Titre abrégé: Clin Genitourin Cancer
Pays: United States
ID NLM: 101260955

Informations de publication

Date de publication:
10 2019
Historique:
received: 23 04 2019
revised: 13 07 2019
accepted: 15 07 2019
pubmed: 14 8 2019
medline: 24 6 2020
entrez: 13 8 2019
Statut: ppublish

Résumé

The purpose of this study was to assess patient frailty as a risk factor for radical cystectomy (RC) complications. We performed an analysis of prospectively collected data of consecutive patients 80 years of age or older who underwent RC and ureterocutaneostomy in 6 primary care European urology centers. Frailty was measured using a simplified frailty index (sFI) with a 5-item score including: (1) diabetes mellitus; (2) functional status; (3) chronic obstructive pulmonary disease; (4) congestive cardiac failure; and (5) hypertension, with a maximum 5-item score meaning high level of frailty. Within 90 days surgical complications were scored according to the Clavien Classification System (CCS). sFI ≥3 was considered as poor frailty status. Clinical and pathological variables were analyzed as predictors of severe complications (CCS ≥3). One hundred seventeen patients were enrolled. Most patients reported an sFI score of 2 and 3, respectively, 31/117 (26.5%) and 45/117 patients (38.5%). CCS ≥3 occurred in 17/117 patients (14.5%). Patients with sFI ≥3 were significantly older than patients with sFI <3 (median age, 85 years [interquartile range (IQR), 82-86] versus 82 years [IQR, 80-84]; P = .001). Most CCS ≥3 scores occurred in patients with sFI ≥3: 13 (11.1%) versus 4 (3.4%; P = .02). No significative differences were detected in terms of length of hospital stay, pathological stage, and postoperative bowel canalization when related to sFI. sFI ≥3 was an independent risk factor of CCS ≥3 in univariate and multivariate analysis (respectively, odds ratio [OR], 3.81 [95% confidence interval (CI), 1.16-12.5; P = .02] and OR, 3.1 [95% CI, 0.7-13.7; P = .01]). Body mass index, age, American Society of Anesthesiologists score ≥3, and pathological stage were not related to CCS ≥3. RC appears feasible in elderly patients with an sFI <3. In cases of sFI ≥3, this choice should be carefully valued, discussed, and possibly avoided because of a higher risk of complications.

Sections du résumé

BACKGROUND
The purpose of this study was to assess patient frailty as a risk factor for radical cystectomy (RC) complications.
MATERIALS AND METHODS
We performed an analysis of prospectively collected data of consecutive patients 80 years of age or older who underwent RC and ureterocutaneostomy in 6 primary care European urology centers. Frailty was measured using a simplified frailty index (sFI) with a 5-item score including: (1) diabetes mellitus; (2) functional status; (3) chronic obstructive pulmonary disease; (4) congestive cardiac failure; and (5) hypertension, with a maximum 5-item score meaning high level of frailty. Within 90 days surgical complications were scored according to the Clavien Classification System (CCS). sFI ≥3 was considered as poor frailty status. Clinical and pathological variables were analyzed as predictors of severe complications (CCS ≥3).
RESULTS
One hundred seventeen patients were enrolled. Most patients reported an sFI score of 2 and 3, respectively, 31/117 (26.5%) and 45/117 patients (38.5%). CCS ≥3 occurred in 17/117 patients (14.5%). Patients with sFI ≥3 were significantly older than patients with sFI <3 (median age, 85 years [interquartile range (IQR), 82-86] versus 82 years [IQR, 80-84]; P = .001). Most CCS ≥3 scores occurred in patients with sFI ≥3: 13 (11.1%) versus 4 (3.4%; P = .02). No significative differences were detected in terms of length of hospital stay, pathological stage, and postoperative bowel canalization when related to sFI. sFI ≥3 was an independent risk factor of CCS ≥3 in univariate and multivariate analysis (respectively, odds ratio [OR], 3.81 [95% confidence interval (CI), 1.16-12.5; P = .02] and OR, 3.1 [95% CI, 0.7-13.7; P = .01]). Body mass index, age, American Society of Anesthesiologists score ≥3, and pathological stage were not related to CCS ≥3.
CONCLUSION
RC appears feasible in elderly patients with an sFI <3. In cases of sFI ≥3, this choice should be carefully valued, discussed, and possibly avoided because of a higher risk of complications.

Identifiants

pubmed: 31402279
pii: S1558-7673(19)30218-6
doi: 10.1016/j.clgc.2019.07.002
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

402-407

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Cosimo De Nunzio (C)

Department of Urology, Ospedale Sant'Andrea-Università di Roma "Sapienza", Rome, Italy. Electronic address: cosimodenunzio@virgilio.it.

Antonio Cicione (A)

Department of Urology, Ospedale Sant'Andrea-Università di Roma "Sapienza", Rome, Italy.

Laura Izquierdo (L)

Department of Urology, Hospital Clinic of Barcelona, Barcelona, Spain.

Riccardo Lombardo (R)

Department of Urology, Ospedale Sant'Andrea-Università di Roma "Sapienza", Rome, Italy.

Giorgia Tema (G)

Department of Urology, Ospedale Sant'Andrea-Università di Roma "Sapienza", Rome, Italy.

Giuseppe Lotrecchiano (G)

Department of Urology, Ospedale Civile, Benevento, Italy.

Andrea Minervini (A)

Department of Urology, Ospedale Careggi, University of Florence, Florence, Italy.

Giuseppe Simone (G)

Department of Urology, "Regina Elena" National Cancer Institute, Rome, Italy.

Luca Cindolo (L)

Department of Urology, "S. Pio" Hospital, Vasto, Italy.

Carlo D'Orta (C)

Department of Urology, "S. Pio" Hospital, Vasto, Italy.

Tarek Ajami (T)

Department of Urology, Hospital Clinic of Barcelona, Barcelona, Spain.

Alessandro Antonelli (A)

Department of Urology, "Spedali Civili," Brescia, Italy.

Marco Dellabella (M)

Department of Urology, IRCCS-INRCA, Ancona, Italy.

Antonio Alcaraz (A)

Department of Urology, Hospital Clinic of Barcelona, Barcelona, Spain.

Andrea Tubaro (A)

Department of Urology, Ospedale Sant'Andrea-Università di Roma "Sapienza", Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH